Skip to main content

Lis Boyce

Partner

Profile

Lis is a trusted corporate lawyer with a reputation for combining sharp legal expertise with a deep understanding of business strategy. She advises listed and private companies, multinationals, and not-for-profit organisations on governance, structure, operations, and growth. Her clients value her ability to build enduring relationships and immerse herself in their culture, ensuring advice that is timely, practical, and aligned with their vision.

At the strategic level, Lis partners with boards and senior executives on high-impact transactions — from capital raisings and restructures to strategic collaborations and mergers & acquisitions. Her extensive experience and pragmatic insights are particularly sought after by growing organisations navigating complex projects.

Lis also helps organisations strengthen governance frameworks, making them fit for purpose and future-ready. She brings emotional intelligence to sensitive matters such as member approvals and conflicts of interest, drawing on her credentials as a graduate of the Australian Institute of Company Directors. For listed entities, she provides clear, actionable guidance on continuous disclosure obligations.

Operationally, Lis champions a practical approach to embedding compliance in everyday operations. She trains boards and managers on key legal duties, designs contract review frameworks aligned with risk appetite, and negotiates complex agreements with precision.

Her deep understanding of the Life Sciences and Healthcare sector is reflected in her leadership roles:

  • Co-Chair, Piper Alderman Life Sciences and Healthcare focus group
  • Non-Executive Director, Immutep Ltd (ASX: IMM; NASDAQ: IMMP)
  • Chair, AusBiotech NSW State Committee

A regular speaker at AusBiotech conferences, ANDHealth workshops, and BioShares masterclasses, Lis is a natural connector, fostering collaboration and strengthening Australia’s life sciences ecosystem.

Expertise

Recognition

“Lis has a high profile and provides timely and helpful guidance on commercial and corporate matters.”
Chambers Asia Pacific Guide: Life Sciences, 2025 edition

“Lis provides amazing advice and remains knowledgeable on current topics and trends.”
Chambers Asia Pacific Guide: Life Sciences, 2025 edition

“Lis is a wonderful asset to the Australian life sciences community, with a very service-oriented approach to her clients.”
Chambers Asia Pacific Guide: Life Sciences, 2023 edition

“She has always been my point person and is always readily available to talk through any prickly topics. And the speed to provide the advice is second to none. Very much appreciated in a competitive market.”
Chambers Asia Pacific Guide: Life Sciences, 2023 edition

Lis Boyce is very commercial, personally engaged, quick to call in further expertise from within the firm where required. Lis has been actively involved in our matters and has helped us resolve several difficult situations with investors relating to contract technicalities, debt and equity maturity, and conversion, adjustment of shareholdings, deal documentation.”
The Legal 500 Asia-Pacific: Corporate and M&A, 2021 edition – Testimonials


Accolades

  • Chambers Asia-Pacific Guide – Life Sciences – Band 4 since 2021 edition
  • Best Lawyers in Australia – Recognised for Life Sciences Practice (Sydney, AU) – since 2020 edition
  • The Legal 500 Asia-Pacific – Recognised ‘Key Lawyer’ for Corporate and M&A – 2021 to 2024 editions


Recent deals and media coverage

Memberships

  • Graduate, Australian Institute of Company Directors
  • Fellow, Governance Institute of Australia
  • Senior Fellow, Financial Services Institute of Australasia

Related Insights

Related News

Insights

Case Studies